Lotronex

Active Ingredient(s): Alosetron
FDA Approved: * February 9, 2000
Pharm Company: * GLAXOSMITHKLINE
Category: Irritable Bowel Syndrome

Alosetron, sold under the brand name Lotronex among others, is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It was patented in 1987 and approved for medical use in 2002.[1] It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Lotronex .5 mg Oral Tablet
NDC: 54766-894
Labeler:
Sebela Pharmaceuticals Inc.
Lotronex 1 mg Oral Tablet
NDC: 54766-895
Labeler:
Sebela Pharmaceuticals Inc.
Lotronex 0.5 mg Oral Tablet
NDC: 65483-894
Labeler:
Prometheus Laboratories Inc.
Lotronex 1 mg Oral Tablet
NDC: 65483-895
Labeler:
Prometheus Laboratories Inc.